尿液檢查市場規模、佔有率和成長分析（按檢測方法、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，全球尿液檢查市場規模將達到 25.1 億美元，到 2025 年將達到 26.2 億美元，到 2033 年將達到 36.9 億美元，預測期（2026-2033 年）的複合年成長率為 4.4%。

全球尿液檢查市場正經歷顯著成長，這主要得益於醫療設備的進步以及糖尿病等慢性疾病的日益增加。醫療基礎設施的不斷改善和未被滿足的醫療需求不斷增加，推動了尿液分析儀、測試紙和質控液等產品的需求激增，尤其是在新興市場。此外，政府主導的篩檢計畫對於早期發現腎臟和泌尿系統疾病至關重要，也進一步促進了市場成長。男性和女性尿道感染（UTI）的高發生率也促使人們需要進行尿液檢查以識別各種健康問題。總體而言，隨著醫療服務提供者優先開發和採用創新尿液檢查技術，預計該市場將持續強勁成長。

推動全球尿液檢查市場發展的因素

發展中地區尿道感染（UTI）的增加是推動全球尿液檢查市場成長的關鍵因素。這些感染疾病可能導致嚴重的併發症，尤其是在分娩期間；如果不及時治療，感染也會擴散到腎臟，因此迫切需要可靠的診斷解決方案。人們對泌尿道感染相關健康影響的認知不斷提高，促使對高效尿液檢查的需求增加，以便早期發現和治療。這一趨勢是由人們對健康的關注以及對改善醫療基礎設施的需求共同推動的，預計將進一步促進市場發展。

全球尿液檢查市場面臨的限制因素

全球尿液檢查市場面臨嚴峻挑戰，尤其是在價格敏感的發展中地區，消費者傾向於選擇功能相當但價格較低廉的設備。缺乏健全的法規結構進一步加劇了這一趨勢，導致大量不合格和翻新產品湧入市場。這些劣質產品不僅會降低醫療服務質量，還會危及病人安全和治療效果。因此，這些市場對高品質、創新尿液檢查解決方案的需求可能疲軟，從而阻礙整體成長，並可能對公共衛生造成影響。

全球尿液檢查市場趨勢

在全球診斷技術進步的推動下，全球尿液檢查市場正經歷著變革性的轉變。尿液分析儀的自動化以及基於智慧型手機的檢測設備的整合，提高了尿液檢查的準確性和便捷性，使患者和醫療服務提供者都能從中受益。隨著糖尿病和腎臟病等慢性疾病的持續成長，對高效尿液檢查方法的需求日益迫切，這對於疾病的早期發現和持續管理至關重要。這種不斷變化的市場格局凸顯了尿液檢查在現代醫學中的關鍵作用，鞏固了其作為監測健康狀況和改善患者預後的重要工具的地位。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球尿液檢查市場規模（按檢測類型和複合年成長率分類）（2026-2033 年）

• 妊娠和不孕症檢查
• 尿液檢查
• 尿液檢查

全球尿液檢查市場規模（按應用領域分類）及複合年成長率（2026-2033 年）

• 疾病篩檢
• 懷孕和生育治療

全球尿液檢查市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院和診所
• 診斷檢查室
• 居家醫療環境
• 研究實驗室和機構

全球尿液檢查市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Cardinal Health（US）
• General Electric Company（US）
• Metropolis India（India）
• 77 Elektronika Kft（Hungary）
• Roche Diagnostics（Switzerland）
• Thermo Fisher Scientific（US）
• Sysmex Corporation（Japan）
• Abbott（US）
• Trinity Biotech（Ireland）
• ARKRAY Inc.（Japan）
• Dr Lal PathLabs（India）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Siemens（Germany）
• Sysmex Corporation（Japan）
• BioMaxima SA（Poland）

結論與建議

Global Urinalysis Test Market size was valued at USD 2.51 Billion in 2024 and is poised to grow from USD 2.62 Billion in 2025 to USD 3.69 Billion by 2033, growing at a CAGR of 4.4% during the forecast period (2026-2033).

The global urinalysis test market is witnessing significant growth, propelled by advancements in medical equipment and the increasing prevalence of chronic diseases such as diabetes. Enhanced healthcare infrastructure and rising unmet healthcare needs are contributing to a surge in demand for urine analyzers, strips, and control solutions, particularly in emerging markets. Additionally, government-led screening programs are crucial for early detection of renal and urological issues, further stimulating market growth. The high incidence of urinary tract infections, prevalent among both men and women, is also driving the need for urinalysis testing to identify various health concerns. Overall, the market is positioned for robust expansion as healthcare providers prioritize the development and implementation of innovative urinalysis technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Test Market Segments Analysis

Global Urinalysis Test Market is segmented by Application, End User, Test and region. Based on Test, the market is segmented into Pregnancy & Fertility Tests, Biochemical Urinalysis and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening and Pregnancy and Fertility. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinalysis Test Market

The increasing incidence of urinary tract infections (UTIs) in developing regions serves as a significant catalyst for the growth of the global urinalysis test market. These infections can lead to serious complications, particularly during childbirth, and may ascend to the kidneys if left untreated, highlighting the urgent need for reliable diagnostic solutions. As awareness of the health implications associated with UTIs rises, there is a growing demand for efficient urinalysis testing to facilitate early detection and treatment. This trend is expected to propel the market forward, driven by both health concerns and the need for improved healthcare infrastructure.

Restraints in the Global Urinalysis Test Market

The Global Urinalysis Test market faces significant challenges due to the preference for cost-effective devices with similar functionalities, particularly in price-sensitive developing regions. This trend is exacerbated by a lack of robust regulatory frameworks, which can lead to an influx of substandard and reconditioned products flooding the market. Such inferior goods not only undermine the quality of healthcare services but also pose risks to patient safety and treatment efficacy. Consequently, the demand for higher-quality and innovative urinalysis solutions may struggle in these markets, hindering overall growth and potentially affecting public health outcomes.

Market Trends of the Global Urinalysis Test Market

The Global Urinalysis Test market is witnessing a transformative shift driven by advancements in diagnostic technology. Automation in urine analyzers and the integration of smartphone-based testing devices are enhancing the accuracy and accessibility of urinalysis, facilitating easier testing for both patients and healthcare providers. As chronic conditions, such as diabetes and renal disease, continue to rise, the demand for effective urinalysis methods becomes increasingly vital for early detection and ongoing management. This evolving landscape underscores the critical role of urinalysis in contemporary healthcare, solidifying its status as an indispensable tool for monitoring health and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Urinalysis Test Market Size by Test & CAGR (2026-2033)

• Market Overview
• Pregnancy & Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Global Urinalysis Test Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Screening
• Pregnancy and Fertility

Global Urinalysis Test Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care Setting
• Research Laboratories & Institute

Global Urinalysis Test Market Size & CAGR (2026-2033)

• North America (Application, End User, Test)
  • US
  • Canada
• Europe (Application, End User, Test)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End User, Test)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End User, Test)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End User, Test)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Cardinal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metropolis India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 77 Elektronika Kft (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr Lal PathLabs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMaxima SA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations